Ascletis Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 86.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
52.7%	Jinzi Jason Wu	515,549,164	€93.9m	0%	no data
10.8%	Yang Dan	105,463,060	€19.2m	0%	no data
8.46%	Lakemont Holding Llc	82,827,414	€15.1m	0%	no data
6.4%	Jjw11 Limited	62,689,872	€11.4m	0%	no data
5.18%	CBC Investment Twelve Limited	50,729,518	€9.2m	0%	no data
1.37%	CBC Investment Fifteen Limited	13,425,209	€2.4m	0%	no data
0.34%	E Fund Management Co., Ltd.	3,285,000	€598.1k	-58.4%	no data
0.27%	Dimensional Fund Advisors LP	2,691,000	€490.0k	-28.8%	no data
0.23%	JP Morgan Asset Management	2,265,000	€412.4k	-17.6%	no data
0.19%	China Universal Asset Management Company Ltd.	1,818,000	€331.0k	0%	no data
0.16%	Fullgoal Fund Management Co. Ltd.	1,591,000	€289.7k	0%	no data
0.12%	Hejingdao Wu	1,155,500	€210.4k	0%	no data
0.051%	China Southern Asset Management Co., Ltd.	500,000	€91.0k	0%	no data
0.019%	American Century Investment Management Inc	186,000	€33.9k	0%	no data